GHK-Cu

What is GHK-Cu?

GHK-Cu is a small natural peptide, glycyl-L-histidyl-L-lysine, bound to a copper ion. GHK is found in human blood plasma, saliva and urine, and its levels fall with age.² It was identified in the 1970s by Loren Pickart, who has since written much of the research literature on it. GHK grips copper with an affinity similar to the copper-carrying site on albumin, the main blood protein, and the resulting complex is GHK-Cu.⁷

GHK-Cu has been used in skin-care products for decades, where it is often sold as copper peptide or copper tripeptide-1. It is marketed for firmer skin, fewer fine lines, wound healing and hair growth.

More recently, injectable GHK-Cu has been offered by some clinics, telehealth services and research-chemical sellers for tissue repair, joint pain and general anti-aging. That use has much less support than the topical one, and it is not approved.

How GHK-Cu works

When skin or other tissue is injured, the body first cleans up the damage and then rebuilds. GHK-Cu appears to act as a signal in that rebuilding phase. It attracts repair cells to the injured area, calms inflammation and prompts skin cells to make more collagen and elastin, the proteins that keep skin firm and springy. It also delivers copper, which several repair enzymes need.

In more detail, GHK stimulates the synthesis of collagen, dermatan sulfate, chondroitin sulfate and the proteoglycan decorin, and it adjusts the activity of the enzymes that break down tissue and their inhibitors, so it supports both building and remodeling.² Laboratory work shows it attracts macrophages, mast cells and capillary cells, suppresses free-radical damage and raises production of growth factors such as VEGF and FGF-2.⁷ Gene-expression analyses suggest GHK can shift the activity of thousands of human genes toward patterns linked with repair.¹ Those gene data come from computer comparisons of cell-line databases, not from treating people.

What the research shows on GHK-Cu

The best evidence is for topical use on aging skin. Controlled studies of GHK-Cu creams reported tighter skin, better elasticity and firmness, fewer fine lines and wrinkles, and less sun damage and hyperpigmentation.⁷ In animals, GHK speeds wound healing of skin, hair follicles, the gut and bone, and it improved healing in rats, mice and pigs.² A 2026 review of peptides in aesthetic medicine described skin rejuvenation as one of the more promising uses of therapeutic peptides, while calling for more research.⁸ For hair, GHK-Cu increased hair follicle size in laboratory work and has been reported to improve hair transplant success,⁷ but controlled trials comparing copper-peptide hair products with established treatments are lacking.

These results have limits. Many cosmetic studies were small, short and sponsored by ingredient makers, and much of the summarizing literature comes from GHK's discoverer and colleagues. Getting GHK-Cu into skin is also a challenge. The complex is water-loving and passes poorly through the skin's outer layer. Liposomes might help, but a 2025 review found that how well liposomal GHK-Cu penetrates skin has received little study.⁶

Evidence for injected GHK-Cu is much weaker. A 2026 primer for orthopaedic surgeons found that GHK-Cu showed promise for wound healing and inflammation, but that no clinical data support its use for musculoskeletal conditions.³ A 2026 Sports Medicine review grouped it with unapproved peptides for which rigorous human safety data are scarce.⁵ Another review of peptides in orthopaedics described promising preclinical work but a lack of clinical trials.⁴

Studied for: Skin repair and anti-ageing, Wound healing, Hair follicle stimulation.

GHK-Cu reference data

GHK-Cu dosage in published research

Open this in the dosage calculator ↗

How GHK-Cu is used in practice

Topical GHK-Cu is widely sold in serums, creams and hair products, from drugstore brands to dermatology lines, with no prescription needed. Concentrations vary and are rarely verified, and the blue tint of some products is not a reliable sign of strength. Like most anti-aging topicals, it needs consistent use for at least several weeks before any change is visible, and it does not replace sunscreen.

Injectable GHK-Cu has been prescribed by some anti-aging clinics and telehealth services as compounded vials, and research-chemical sellers offer larger vials of powder. Users inject it under the skin daily or several times a week, sometimes mixed with other peptides. Its compounding status is covered in the legal status box on this page.

Research-chemical products are not tested for identity, copper content, sterility or endotoxin. Whatever the source, there is no approved dose for injection.

GHK-Cu risks and side effects

Topical GHK-Cu is generally well tolerated. The usual side effects are mild irritation and temporary redness. Some dermatologists advise against applying it at the same time as strong acids or high-strength vitamin C, which may destabilize the copper complex or irritate the skin. Allergic skin reactions are uncommon but possible, so people with sensitive skin or a history of reactions to cosmetics may want to test a small area first.

Injection raises different questions. Side effects reported include injection-site pain, redness and lumps. The long-term effects of repeatedly delivering a growth-promoting signal and extra copper into the bloodstream have not been studied. People with Wilson disease or other copper-overload conditions should avoid it. Injectable use during pregnancy is not advised.

Some reviews describe anticancer effects of GHK in laboratory studies,¹ but GHK also promotes new blood vessel growth, and neither effect has been studied in people with cancer. Contamination and dosing errors are real risks with unregulated injectables.

Reported side effects

Alternatives to GHK-Cu

For aging skin, daily broad-spectrum sunscreen and topical retinoids have the strongest evidence. Prescription tretinoin is FDA-approved for treating sun damage and fine wrinkles, and over-the-counter retinol is a milder option. Vitamin C serums, chemical peels, microneedling and laser treatments are other choices with a dermatologist.

For hair loss, topical and oral minoxidil and, in men, finasteride have far more trial evidence than copper peptides. For chronic wounds, standard wound care is the foundation, and becaplermin gel is FDA-approved for certain diabetic foot ulcers. For tendon and joint injuries, physical therapy and loading programs have the best evidence.

Questions for a clinician

• What evidence applies to my situation, and at what level?
• What established alternatives should I consider first?
• What monitoring would be necessary, and how often?